Cryo + Intralesional Steroid Combination Therapy Cost in Korea

Mijan Mijan • July 27, 2025

Cryo + Intralesional Steroid Combination Therapy Cost in Korea

Cryo + Intralesional Steroid Combination Therapy is a synergistic treatment commonly used in Korea to manage hypertrophic scars, keloids, stubborn warts, or inflamed skin lesions. The cryotherapy component freezes abnormal tissue with liquid nitrogen, while the corticosteroid injection reduces inflammation and scar tissue formation. This dual approach is widely performed in dermatology clinics across Korea for faster and more effective outcomes.

๐Ÿ“Š Comprehensive Cost Overview

Treatment Type Estimated Cost (KRW) Use Case
Cryotherapy + Steroid (Single Lesion) 80,000 – 150,000 Keloid or hypertrophic scar
Cryo + Steroid (Multiple Lesions) 150,000 – 300,000 Multiple scars or resistant warts
High-Dose Steroid Add-On +30,000 – 60,000 For thicker or recurring lesions

๐Ÿงพ Detailed Cost Analysis by Component

Component Cost (KRW) Details
Cryotherapy (Liquid Nitrogen Application) 30,000 – 80,000 Tissue freezing per lesion
Intralesional Steroid Injection 50,000 – 120,000 Triamcinolone or equivalent steroid
Topical Anesthesia (Optional) 10,000 – 20,000 Applied to minimize injection discomfort

๐Ÿงฉ Additional & Optional Services Cost

Service Cost (KRW) Purpose
Antibacterial Ointment 5,000 – 10,000 Prevents infection post-treatment
Hydrocolloid Dressing 3,000 – 6,000 per patch For faster wound recovery
Follow-Up Evaluation 10,000 – 30,000 Assessment of scar/wart response

๐Ÿฅ Clinical Treatment Costs

Clinic Type Session Cost (KRW) Remarks
General Dermatology Clinic 100,000 – 180,000 Standard cryo + steroid combo
Specialized Scar or Wart Clinic 150,000 – 300,000 Advanced formulation or protocols
By Mijan Mijan August 3, 2025
By Mijan Mijan August 3, 2025
By Mijan Mijan August 3, 2025
By Mijan Mijan August 3, 2025
By Mijan Mijan August 3, 2025
This is a subtitle for your new post
By Mijan Mijan August 3, 2025
This is a subtitle for your new post
By Mijan Mijan August 3, 2025